Clinical Trial Update: Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rivaroxaban for anticoagulation in the early postoperative period after bioprosthetic valve replacement; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bioprosthetic Valve Replacement
• Valvular Heart Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: RenJi Hospital | Conditions: Anticoagulation | Phase 4 | Status: NOT_YET_RECRUITING